DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Catalyst Pharmaceuticals Q4 EPS $0.07 Misses $0.1 Estimate, Sales $30M Beat $29.4M Estimate

Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.1 by 30 percent. This is a 150 percent increase over losses of $(0.14) per share

Benzinga · 03/16/2020 21:28

Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.1 by 30 percent. This is a 150 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $30 million which beat the analyst consensus estimate of $29.4 million by 2.04 percent. This is a 5.90K percent increase over sales of $500 thousand the same period last year.